Abstract: Provided herein are methods for measuring concentration of circulating cell free DNA (cfDNA) from a sample of a subject, for the purposes of cancer or tumor detection and/or characterization.

Abstract: Provided herein are methods and kits for measuring genome wide copy number aberrations, including aneuploidies, in animals, such as in dogs, for the purposes of cancer detection or characterization or management. Also provided are particular motifs for use in measuring copy number variants including aneuploidies genome-wide in animals, such as in dogs.

Abstract: The systems and methods herein aid in coordinating the activities of disparate entities for assessing the status of cancer or other diseases in pets. A streamlined process by the systems and methods herein allow consumers to expedite the logistics for receiving medical kits, setting up an appointment with a clinician, sending a sample associated with medical tests to a testing lab, and assessing the health of the pet based on the sample. By coordinating these activities by the systems and methods herein, earlier stage diagnosis of the consumer's pet can be achieved.